Breaking News
Get 55% Off 0
🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% each
Unlock Stocks
Close

Amundi MSCI World Health Care UCITS ETF EUR Acc (LYXHLTW)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
492.03 -3.73    -0.75%
17:35:59 - Closed. Currency in EUR
Type:  ETF
Market:  France
Issuer: 
ISIN:  LU0533033238 
Asset Class:  Equity
  • Volume: 925
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 491.79 - 496.63
Amundi MSCI World Health Care UCITS ETF EUR Acc 492.03 -3.73 -0.75%

LYXHLTW Recent Sentiments

 
Information on users’ sentiments for the Amundi MSCI World Health Care UCITS ETF EUR Acc ETF, which are displayed both on charts of different periods of time and on a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
Nov 11, 2024 Miguel Dasacco   502.27 -2.04%
Oct 30, 2024 Mathis Trade   492.00 +0.01%
Oct 04, 2024 Pierre CAZALS   497.72 Oct 07, 2024 @ 498.67 +0.19%
Sep 13, 2024 Miguel Dasacco   509.10 Sep 16, 2024 @ 509.86 +0.15%
Aug 19, 2024 faouzi oulmi   505.09 Sep 13, 2024 @ 509.91 +0.95%
Jul 10, 2024 Alain Dumont   485.80 Aug 02, 2024 @ 493.53 +1.59%
Jun 17, 2024 Mehdy Boussaboua   486.77 Jul 12, 2024 @ 493.86 +1.46%
May 16, 2024 Edgard Sisto   482.63 Jun 07, 2024 @ 489.48 +1.42%
Apr 15, 2024 Ida Paul   469.12 Apr 15, 2024 @ 470.26 +0.24%
Mar 20, 2024 leon duck   479.22 Apr 12, 2024 @ 469.12 -2.11%
Apr 04, 2023 Easy Sport   428.55 May 09, 2023 @ 438.13 +2.24%
Oct 13, 2022 Christophe Vial   431.83 Nov 04, 2022 @ 450.00 +4.21%
Aug 25, 2022 Alexis Reviron   453.42 Sep 16, 2022 @ 436.70 -3.69%
Aug 08, 2022 Christophe Vial   450.52 Sep 02, 2022 @ 440.55 +2.21%
Aug 02, 2022 JM B   450.58 Aug 08, 2022 @ 450.53 -0.01%
Jun 16, 2022 Dieter Chlechowitz   401.87 Jun 16, 2022 @ 398.80 +0.76%
May 25, 2022 Mario Hernández   426.35 Jun 17, 2022 @ 403.67 +5.32%
Dec 15, 2021 gene deke   429.08 Jan 07, 2022 @ 421.90 -1.67%
Jul 14, 2021 Omar Azzouzi   395.72 Aug 06, 2021 @ 407.15 +2.89%
Feb 26, 2021 Alexandre Thalmann   343.00 Mar 19, 2021 @ 351.76 +2.55%
Sep 15, 2020 Antonio Caterino   333.65 Oct 09, 2020 @ 339.95 +1.89%
Jun 18, 2020 Benjamin Allègre   333.98 Jul 10, 2020 @ 332.90 -0.32%
Jun 09, 2020 Alain Ahebie   338.16 Jul 03, 2020 @ 338.07 -0.03%
Jun 02, 2020 Stefano Sbarra   338.12 Jun 26, 2020 @ 330.40 -2.28%
Apr 30, 2020 Vincenzo Spampinato   337.99 May 22, 2020 @ 338.28 +0.09%
Apr 17, 2020 Pedro Aguilera   335.06 Apr 25, 2020 @ 336.46 +0.42%
Feb 25, 2020 Sébastien Lé   339.86 Mar 20, 2020 @ 277.81 -18.26%
Feb 19, 2020 Paul Rdgz   352.52 Mar 13, 2020 @ 283.96 -19.45%
Jan 10, 2020 pat piet   337.73 Jan 31, 2020 @ 330.06 +2.27%
Dec 11, 2019 Paul Rdgz   323.53 Jan 03, 2020 @ 331.23 +2.38%
Nov 06, 2019 gilberto gaianigo   306.62 Nov 29, 2019 @ 325.54 +6.17%
Sep 19, 2019 gilberto gaianigo   296.87 Oct 11, 2019 @ 297.18 +0.10%
Sep 11, 2019 Louis Schenk   296.87 Oct 04, 2019 @ 294.28 -0.87%
Jun 04, 2019 Alen Jakupovic   276.15 Jun 04, 2019 @ 276.15 0.00%
May 18, 2018 Dr Matt   251.30 Jun 17, 2018 @ 258.79 +2.98%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

LYXHLTW Comments

Write your thoughts about Amundi MSCI World Health Care UCITS ETF EUR Acc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email